Female Health Co (FHCO): O B Parrish , CEO of Female Health Co purchased 10,000 shares on May 24, 2016. The Insider buying transaction was reported by the company on May 25, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.29 per share for a total value of $12,909.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 24, 2016, William R Jr Gargiulo (director) purchased 500 shares at $1.26 per share price.On May 23, 2016, David R Bethune (director) purchased 100 shares at $1.26 per share price.Also, On Dec 28, 2015, Andrew S Jr Love (director) purchased 25,000 shares at $1.45 per share price.On Dec 21, 2015, O B Parrish (CEO) purchased 10,000 shares at $1.48 per share price.
Shares of Female Health Co (FHCO) ended Friday, May 20, 2016 session in red amid volatile trading. The shares closed down -0.03 points or -2.34% at $1.25 with 87,528 shares getting traded. Post opening the session at $1.3, the shares hit an intraday low of $1.25 and an intraday high of $1.31 and the price vacillated in this range throughout the day. The company has a market cap of $36 M and the number of outstanding shares has been calculated to be 2,90,52,667 shares. The 52-week high of Female Health Co is $2.75 and the 52-week low is $1.16.
The Female Health Company is a Female Condom company. The Company is engaged in manufacturing marketing and selling FC2 Female Condom (FC2). FC2 is used for both disease prevention and family planning the public health sector is the Companys market. The Company operates in one industry segment which includes the development manufacture and marketing of consumer health care products. The FC2 product offered by the Company facilitates dual protection for women against both unintended pregnancy and STIs including HIV and AIDS its market encompasses both family planning and disease prevention. FC2s primary usages are for disease prevention and family planning the public health sector is the Companys main market. The Company markets products that prevent the transmission of HIV and AIDS through sexual intercourse: the male condom and FC2.